Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6280-6288
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6280
Figure 3
Figure 3 Clinical course of the patient. ABPC: Ampicillin; Ag: Antigenemia; CRP: C-reactive protein; CT: Computed tomography; CMV: Cytomegalovirus; DNA: Deoxyribonucleic acid; MEPM: meropenem; PIPC/TAZ: piperacillin/tazobactam; P. jirovecii: Pneumocystis jirovecii; S. pneumoniae: Streptococcus pneumoniae; ST: Sulfamethoxazole and trimethoprim; VCM: Vancomycin; VRCZ: Voriconazole; WBC: White blood cell; β-DG: β-D glucan.

  • Citation: Usuda D, Kato M, Sugawara Y, Shimizu R, Inami T, Tsuge S, Sakurai R, Kawai K, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Secondary pulmonary infection by Fusarium solani and Aspergillus niger during systemic steroid treatment for COVID-19: A case report. World J Clin Cases 2023; 11(26): 6280-6288
  • URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6280.htm
  • DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6280